Last Andrew J.
Insider CIK 1485088 · BIO, BIOB EVP, Chief Operating Officer · XON Chief Operating Officer · OCX Director · AFFX EVP, Chief Operating Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| IMDX Insight Molecular Diagnost | F Tax w/h | 2026-07-01 | 2026-07-06 | 7,700 | $5.69 | $43.8K | 58,752 | SEC↗ |
| IMDX Insight Molecular Diagnost | A Award | 2026-06-11 | 2026-06-15 | 26,943 | — | $0 | 66,452 | SEC↗ |
| IMDX Insight Molecular Diagnost | A Award | 2025-07-01 | 2025-07-03 | 35,000 | — | $0 | 39,509 | SEC↗ |
| BIO BIOB BIO-RAD LABORATORIES, INC. | M Exercise deriv | 2024-09-06 | 2024-09-10 | 3,000 | — | $0 | 0 | SEC↗ |
| BIO BIOB BIO-RAD LABORATORIES, INC. | M Exercise | 2024-09-06 | 2024-09-10 | 3,000 | $299.24 | $897.7K | 10,559 | SEC↗ |
| BIO BIOB BIO-RAD LABORATORIES, INC. | S Sale | 2024-09-06 | 2024-09-10 | 3,000 | $329.94 | $989.8K | 7,559 | SEC↗ |
| BIO BIOB BIO-RAD LABORATORIES, INC. | M Exercise deriv | 2024-09-02 | 2024-09-04 | 903 | — | $0 | 0 | SEC↗ |
| BIO BIOB BIO-RAD LABORATORIES, INC. | F Tax w/h | 2024-09-02 | 2024-09-04 | 458 | $337.32 | $154.5K | 7,559 | SEC↗ |
| BIO BIOB BIO-RAD LABORATORIES, INC. | M Exercise | 2024-09-02 | 2024-09-04 | 903 | — | $0 | 8,017 | SEC↗ |
| BIO BIOB BIO-RAD LABORATORIES, INC. | M Exercise deriv | 2024-09-01 | 2024-09-04 | 867 | — | $0 | 1,735 | SEC↗ |
| BIO BIOB BIO-RAD LABORATORIES, INC. | M Exercise deriv | 2024-09-01 | 2024-09-04 | 633 | — | $0 | 633 | SEC↗ |
| BIO BIOB BIO-RAD LABORATORIES, INC. | M Exercise deriv | 2024-09-01 | 2024-09-04 | 1,252 | — | $0 | 3,756 | SEC↗ |
| BIO BIOB BIO-RAD LABORATORIES, INC. | F Tax w/h | 2024-09-01 | 2024-09-04 | 321 | $337.32 | $108.3K | 7,114 | SEC↗ |
| BIO BIOB BIO-RAD LABORATORIES, INC. | M Exercise | 2024-09-01 | 2024-09-04 | 1,252 | — | $0 | 7,010 | SEC↗ |
| BIO BIOB BIO-RAD LABORATORIES, INC. | F Tax w/h | 2024-09-01 | 2024-09-04 | 635 | $337.32 | $214.2K | 6,375 | SEC↗ |
| BIO BIOB BIO-RAD LABORATORIES, INC. | M Exercise | 2024-09-01 | 2024-09-04 | 867 | — | $0 | 7,242 | SEC↗ |
| BIO BIOB BIO-RAD LABORATORIES, INC. | F Tax w/h | 2024-09-01 | 2024-09-04 | 440 | $337.32 | $148.4K | 6,802 | SEC↗ |
| BIO BIOB BIO-RAD LABORATORIES, INC. | M Exercise | 2024-09-01 | 2024-09-04 | 633 | — | $0 | 7,435 | SEC↗ |
| OCX Oncocyte Corp | A Award deriv | 2024-07-01 | 2024-07-03 | 30,000 | — | $0 | 30,000 | SEC↗ |
| BIO BIOB BIO-RAD LABORATORIES, INC. | M Exercise deriv | 2024-04-29 | 2024-04-30 | 1,000 | — | $0 | 0 | SEC↗ |
| BIO BIOB BIO-RAD LABORATORIES, INC. | M Exercise | 2024-04-29 | 2024-04-30 | 1,000 | — | $0 | 6,077 | SEC↗ |
| BIO BIOB BIO-RAD LABORATORIES, INC. | F Tax w/h | 2024-04-29 | 2024-04-30 | 357 | $277.11 | $98.9K | 5,720 | SEC↗ |
| BIO BIOB BIO-RAD LABORATORIES, INC. | A Award deriv | 2024-03-08 | 2024-03-12 | 5,891 | — | $0 | 5,891 | SEC↗ |
| BIO BIOB BIO-RAD LABORATORIES, INC. | M Exercise deriv | 2023-09-02 | 2023-09-06 | 903 | — | $0 | 903 | SEC↗ |
| BIO BIOB BIO-RAD LABORATORIES, INC. | M Exercise | 2023-09-02 | 2023-09-06 | 903 | — | $0 | 5,488 | SEC↗ |
| BIO BIOB BIO-RAD LABORATORIES, INC. | F Tax w/h | 2023-09-02 | 2023-09-06 | 448 | $394.60 | $176.8K | 5,040 | SEC↗ |
| BIO BIOB BIO-RAD LABORATORIES, INC. | M Exercise deriv | 2023-09-01 | 2023-09-06 | 867 | — | $0 | 2,602 | SEC↗ |
| BIO BIOB BIO-RAD LABORATORIES, INC. | M Exercise deriv | 2023-09-01 | 2023-09-06 | 633 | — | $0 | 1,266 | SEC↗ |
| BIO BIOB BIO-RAD LABORATORIES, INC. | A Award deriv | 2023-09-01 | 2023-09-06 | 5,008 | — | $0 | 5,008 | SEC↗ |
| BIO BIOB BIO-RAD LABORATORIES, INC. | F Tax w/h | 2023-09-01 | 2023-09-06 | 279 | $394.60 | $110.1K | 4,585 | SEC↗ |
| BIO BIOB BIO-RAD LABORATORIES, INC. | F Tax w/h | 2023-09-01 | 2023-09-06 | 430 | $394.60 | $169.7K | 4,231 | SEC↗ |
| BIO BIOB BIO-RAD LABORATORIES, INC. | M Exercise | 2023-09-01 | 2023-09-06 | 867 | — | $0 | 4,661 | SEC↗ |
| BIO BIOB BIO-RAD LABORATORIES, INC. | M Exercise | 2023-09-01 | 2023-09-06 | 633 | — | $0 | 4,864 | SEC↗ |
| OCX Oncocyte Corp | A Award deriv | 2023-06-23 | 2023-06-27 | 90,000 | — | $0 | 90,000 | SEC↗ |
| OCX Oncocyte Corp | A Award | 2023-06-23 | 2023-06-27 | 20,000 | — | $0 | 90,170 | SEC↗ |
| BIO BIOB BIO-RAD LABORATORIES, INC. | M Exercise deriv | 2023-04-29 | 2023-05-01 | 1,000 | — | $0 | 1,000 | SEC↗ |
| BIO BIOB BIO-RAD LABORATORIES, INC. | M Exercise | 2023-04-29 | 2023-05-01 | 1,000 | — | $0 | 4,113 | SEC↗ |
| BIO BIOB BIO-RAD LABORATORIES, INC. | F Tax w/h | 2023-04-29 | 2023-05-01 | 346 | $450.79 | $156.0K | 3,767 | SEC↗ |
| BIO BIOB BIO-RAD LABORATORIES, INC. | M Exercise deriv | 2022-09-02 | 2022-09-07 | 902 | — | $0 | 1,806 | SEC↗ |
| BIO BIOB BIO-RAD LABORATORIES, INC. | M Exercise | 2022-09-02 | 2022-09-07 | 902 | — | $0 | 3,531 | SEC↗ |
| BIO BIOB BIO-RAD LABORATORIES, INC. | F Tax w/h | 2022-09-02 | 2022-09-07 | 448 | $478.32 | $214.3K | 3,083 | SEC↗ |
| BIO BIOB BIO-RAD LABORATORIES, INC. | A Award deriv | 2022-09-01 | 2022-09-06 | 3,469 | — | $0 | 3,469 | SEC↗ |
| BIO BIOB BIO-RAD LABORATORIES, INC. | M Exercise deriv | 2022-09-01 | 2022-09-06 | 633 | — | $0 | 1,899 | SEC↗ |
| BIO BIOB BIO-RAD LABORATORIES, INC. | F Tax w/h | 2022-09-01 | 2022-09-06 | 314 | $486.25 | $152.7K | 2,629 | SEC↗ |
| BIO BIOB BIO-RAD LABORATORIES, INC. | M Exercise | 2022-09-01 | 2022-09-06 | 633 | — | $0 | 2,943 | SEC↗ |
| OCX Oncocyte Corp | P Buy | 2022-08-17 | 2022-08-19 | 20,000 | $0.87 | $17.4K | 70,170 | SEC↗ |
| OCX Oncocyte Corp | A Award deriv | 2022-08-15 | 2022-08-17 | 45,000 | — | $0 | 45,000 | SEC↗ |
| OCX Oncocyte Corp | A Award | 2022-08-15 | 2022-08-17 | 10,000 | — | $0 | 50,170 | SEC↗ |
| OCX Oncocyte Corp | M Exercise deriv | 2022-06-24 | 2022-07-19 | 10,000 | — | $0 | 0 | SEC↗ |
| OCX Oncocyte Corp | M Exercise | 2022-06-24 | 2022-07-19 | 10,000 | — | $0 | 40,170 | SEC↗ |
| BIO BIOB BIO-RAD LABORATORIES, INC. | M Exercise deriv | 2022-04-29 | 2022-05-02 | 1,000 | — | $0 | 2,000 | SEC↗ |
| BIO BIOB BIO-RAD LABORATORIES, INC. | F Tax w/h | 2022-04-29 | 2022-05-02 | 471 | $512.06 | $241.2K | 2,293 | SEC↗ |
| BIO BIOB BIO-RAD LABORATORIES, INC. | M Exercise | 2022-04-29 | 2022-05-02 | 1,000 | — | $0 | 2,764 | SEC↗ |
| BIO BIOB BIO-RAD LABORATORIES, INC. | M Exercise deriv | 2021-09-02 | 2021-09-03 | 902 | — | $0 | 2,708 | SEC↗ |
| BIO BIOB BIO-RAD LABORATORIES, INC. | M Exercise | 2021-09-02 | 2021-09-03 | 902 | — | $0 | 2,184 | SEC↗ |
| BIO BIOB BIO-RAD LABORATORIES, INC. | F Tax w/h | 2021-09-02 | 2021-09-03 | 448 | $825.77 | $369.9K | 1,736 | SEC↗ |
| BIO BIOB BIO-RAD LABORATORIES, INC. | A Award deriv | 2021-09-01 | 2021-09-03 | 2,532 | — | $0 | 2,532 | SEC↗ |
| BIO BIOB BIO-RAD LABORATORIES, INC. | M Exercise deriv | 2021-09-01 | 2021-09-03 | 2,000 | — | $0 | 3,000 | SEC↗ |
| BIO BIOB BIO-RAD LABORATORIES, INC. | A Award deriv | 2021-09-01 | 2021-09-03 | 2,532 | — | $0 | 2,532 | SEC↗ |
| BIO BIOB BIO-RAD LABORATORIES, INC. | S Sale | 2021-09-01 | 2021-09-03 | 651 | $813.15 | $529.4K | 1,881 | SEC↗ |
| BIO BIOB BIO-RAD LABORATORIES, INC. | S Sale | 2021-09-01 | 2021-09-03 | 599 | $814.09 | $487.6K | 1,282 | SEC↗ |
| BIO BIOB BIO-RAD LABORATORIES, INC. | S Sale | 2021-09-01 | 2021-09-03 | 750 | $812.27 | $609.2K | 2,532 | SEC↗ |
| BIO BIOB BIO-RAD LABORATORIES, INC. | M Exercise | 2021-09-01 | 2021-09-03 | 2,000 | $299.24 | $598.5K | 3,282 | SEC↗ |
| OCX OncoCyte Corp | A Award deriv | 2021-06-24 | 2021-06-28 | 45,000 | — | $0 | 45,000 | SEC↗ |
| OCX OncoCyte Corp | A Award deriv | 2021-06-24 | 2021-06-28 | 10,000 | — | $0 | 10,000 | SEC↗ |
| OCX OncoCyte Corp | X Exercise deriv | 2021-06-11 | 2021-06-14 | 6,993 | — | $0 | 0 | SEC↗ |
| OCX OncoCyte Corp | X Exercise | 2021-06-11 | 2021-06-14 | 6,993 | $3.00 | $21.0K | 30,170 | SEC↗ |
| BIO BIOB BIO-RAD LABORATORIES, INC. | M Exercise deriv | 2021-04-29 | 2021-04-30 | 1,000 | — | $0 | 3,000 | SEC↗ |
| BIO BIOB BIO-RAD LABORATORIES, INC. | M Exercise | 2021-04-29 | 2021-04-30 | 1,000 | — | $0 | 1,734 | SEC↗ |
| BIO BIOB BIO-RAD LABORATORIES, INC. | F Tax w/h | 2021-04-29 | 2021-04-30 | 466 | $640.73 | $298.6K | 1,268 | SEC↗ |
| OCX | A Award | 2020-12-11 | 2020-12-15 | 16,184 | — | $0 | 23,177 | SEC↗ |
| BIO, BIOB BIO-RAD LABORATORIES, INC. | A Award deriv | 2020-09-02 | 2020-09-04 | 3,610 | — | $0 | 3,610 | SEC↗ |
| BIO, BIOB BIO-RAD LABORATORIES, INC. | A Award deriv | 2020-09-02 | 2020-09-04 | 3,610 | — | $0 | 3,610 | SEC↗ |
| OCX OncoCyte Corp | A Award deriv | 2020-06-17 | 2020-06-19 | 57,000 | — | $0 | 57,000 | SEC↗ |
| BIO,BIOB BIO-RAD LABORATORIES, INC. | M Exercise deriv | 2020-04-29 | 2020-04-30 | 1,000 | — | $0 | 4,000 | SEC↗ |
| BIO,BIOB BIO-RAD LABORATORIES, INC. | F Tax w/h | 2020-04-29 | 2020-04-30 | 346 | $436.27 | $150.9K | 680 | SEC↗ |
| BIO,BIOB BIO-RAD LABORATORIES, INC. | M Exercise | 2020-04-29 | 2020-04-30 | 1,000 | — | $0 | 1,026 | SEC↗ |
| OCX OncoCyte Corp | A Award deriv | 2019-07-17 | 2019-07-19 | 45,000 | — | $0 | 45,000 | SEC↗ |
| BIO, BIOB BIO-RAD LABORATORIES, INC. | A Award deriv | 2019-04-29 | 2019-04-30 | 5,000 | — | $0 | 5,000 | SEC↗ |
| BIO, BIOB BIO-RAD LABORATORIES, INC. | A Award deriv | 2019-04-29 | 2019-04-30 | 5,000 | — | $0 | 5,000 | SEC↗ |
| OCX OncoCyte Corp | A Award deriv | 2018-08-30 | 2018-09-04 | 45,000 | — | $0 | 45,000 | SEC↗ |
| OCX OncoCyte Corp | P Buy deriv | 2018-07-26 | 2018-07-31 | 6,993 | — | $0 | 6,993 | SEC↗ |
| OCX OncoCyte Corp | P Buy | 2018-07-26 | 2018-07-31 | 6,993 | — | $0 | 6,993 | SEC↗ |
| XON INTREXON CORP | P Buy | 2017-11-13 | 2017-11-15 | 2,000 | $12.10 | $24.2K | 4,000 | SEC↗ |
| XON INTREXON CORP | P Buy | 2017-08-14 | 2017-08-15 | 2,000 | $19.99 | $40.0K | 2,000 | SEC↗ |
| OCX OncoCyte Corp | A Award deriv | 2017-06-15 | 2017-06-20 | 6,520 | — | $0 | 6,520 | SEC↗ |
| OCX OncoCyte Corp | A Award deriv | 2017-06-15 | 2017-06-20 | 20,000 | — | $0 | 20,000 | SEC↗ |
| XON INTREXON CORP | A Award deriv | 2016-08-29 | 2016-08-31 | 600,000 | — | $0 | 600,000 | SEC↗ |
| AFFX AFFYMETRIX INC | D To issuer deriv | 2016-03-31 | 2016-04-01 | 60,000 | — | $0 | 0 | SEC↗ |
| AFFX AFFYMETRIX INC | D To issuer deriv | 2016-03-31 | 2016-04-01 | 50,000 | — | $0 | 0 | SEC↗ |
| AFFX AFFYMETRIX INC | D To issuer deriv | 2016-03-31 | 2016-04-01 | 51,000 | — | $0 | 0 | SEC↗ |
| AFFX AFFYMETRIX INC | D To issuer deriv | 2016-03-31 | 2016-04-01 | 50,000 | — | $0 | 0 | SEC↗ |
| AFFX AFFYMETRIX INC | D To issuer deriv | 2016-03-31 | 2016-04-01 | 35,817 | — | $0 | 0 | SEC↗ |
| AFFX AFFYMETRIX INC | D To issuer deriv | 2016-03-31 | 2016-04-01 | 31,300 | — | $0 | 0 | SEC↗ |
| AFFX AFFYMETRIX INC | D To issuer deriv | 2016-03-31 | 2016-04-01 | 35,000 | — | $0 | 0 | SEC↗ |
| AFFX AFFYMETRIX INC | D To issuer | 2016-03-31 | 2016-04-01 | 223,548 | — | $0 | 0 | SEC↗ |
| AFFX AFFYMETRIX INC | F Tax w/h | 2016-02-25 | 2016-02-25 | 940 | $14.06 | $13.2K | 223,548 | SEC↗ |
| AFFX AFFYMETRIX INC | F Tax w/h | 2016-02-19 | 2016-02-22 | 4,673 | $13.98 | $65.3K | 226,086 | SEC↗ |
| AFFX AFFYMETRIX INC | F Tax w/h | 2016-02-19 | 2016-02-22 | 1,598 | $13.98 | $22.3K | 224,488 | SEC↗ |
| AFFX AFFYMETRIX INC | A Award | 2016-02-18 | 2016-02-22 | 35,817 | — | $0 | 230,759 | SEC↗ |
| OCX OncoCyte Corp | A Award deriv | 2016-02-16 | 2016-02-18 | 20,000 | — | $0 | 20,000 | SEC↗ |
| AFFX AFFYMETRIX INC | F Tax w/h | 2016-02-14 | 2016-02-17 | 2,819 | $14.09 | $39.7K | 194,942 | SEC↗ |
| AFFX AFFYMETRIX INC | F Tax w/h | 2016-02-13 | 2016-02-17 | 7,466 | $14.09 | $105.2K | 199,943 | SEC↗ |
| AFFX AFFYMETRIX INC | F Tax w/h | 2016-02-13 | 2016-02-17 | 2,182 | $14.09 | $30.7K | 197,761 | SEC↗ |
| AFFX AFFYMETRIX INC | A Award | 2016-02-08 | 2016-02-10 | 37,297 | — | $0 | 207,409 | SEC↗ |
| AFFX AFFYMETRIX INC | M Exercise deriv | 2015-03-25 | 2015-03-26 | 90,000 | — | $0 | 0 | SEC↗ |
| AFFX AFFYMETRIX INC | M Exercise deriv | 2015-03-25 | 2015-03-26 | 20,000 | — | $0 | 50,000 | SEC↗ |
| AFFX AFFYMETRIX INC | S Sale | 2015-03-25 | 2015-03-26 | 110,000 | $12.79 | $1.41M | 170,112 | SEC↗ |
| AFFX AFFYMETRIX INC | M Exercise | 2015-03-25 | 2015-03-26 | 90,000 | $5.29 | $476.1K | 260,112 | SEC↗ |
| AFFX AFFYMETRIX INC | M Exercise | 2015-03-25 | 2015-03-26 | 20,000 | $4.22 | $84.4K | 280,112 | SEC↗ |
| AFFX AFFYMETRIX INC | F Tax w/h | 2015-02-25 | 2015-02-26 | 5,638 | $11.64 | $65.6K | 170,112 | SEC↗ |
| AFFX AFFYMETRIX INC | A Award deriv | 2015-02-19 | 2015-02-19 | 31,300 | — | $0 | 31,300 | SEC↗ |
| AFFX AFFYMETRIX INC | A Award | 2015-02-19 | 2015-02-19 | 17,000 | — | $0 | 175,750 | SEC↗ |
| AFFX AFFYMETRIX INC | F Tax w/h | 2015-02-17 | 2015-02-18 | 940 | $11.77 | $11.1K | 158,750 | SEC↗ |
| AFFX AFFYMETRIX INC | F Tax w/h | 2015-02-14 | 2015-02-18 | 2,837 | $11.45 | $32.5K | 159,690 | SEC↗ |
| AFFX AFFYMETRIX INC | F Tax w/h | 2015-02-13 | 2015-02-18 | 7,509 | $11.45 | $86.0K | 164,717 | SEC↗ |
| AFFX AFFYMETRIX INC | F Tax w/h | 2015-02-13 | 2015-02-18 | 2,190 | $11.45 | $25.1K | 162,527 | SEC↗ |
| AFFX AFFYMETRIX INC | A Award | 2015-02-02 | 2015-02-04 | 40,000 | — | $0 | 172,226 | SEC↗ |
| AFFX AFFYMETRIX INC | F Tax w/h | 2014-08-19 | 2014-08-21 | 1,410 | $8.73 | $12.3K | 132,226 | SEC↗ |
| AFFX AFFYMETRIX INC | F Tax w/h | 2014-02-25 | 2014-02-27 | 5,554 | $7.47 | $41.5K | 133,636 | SEC↗ |
| AFFX AFFYMETRIX INC | F Tax w/h | 2014-02-17 | 2014-02-19 | 1,078 | $7.28 | $7.8K | 139,190 | SEC↗ |
| AFFX AFFYMETRIX INC | F Tax w/h | 2014-02-14 | 2014-02-19 | 3,291 | $7.28 | $24.0K | 140,268 | SEC↗ |
| AFFX AFFYMETRIX INC | A Award deriv | 2014-02-13 | 2014-02-13 | 35,000 | — | $0 | 35,000 | SEC↗ |
| AFFX AFFYMETRIX INC | A Award | 2014-02-13 | 2014-02-13 | 20,000 | — | $0 | 143,559 | SEC↗ |
| AFFX AFFYMETRIX INC | A Award | 2014-02-11 | 2014-02-13 | 35,000 | — | $0 | 123,559 | SEC↗ |
| AFFX AFFYMETRIX INC | F Tax w/h | 2013-12-17 | 2013-12-18 | 1,880 | $8.33 | $15.7K | 88,559 | SEC↗ |
| AFFX AFFYMETRIX INC | F Tax w/h | 2013-08-19 | 2013-08-21 | 1,410 | $4.95 | $7.0K | 90,439 | SEC↗ |
| AFFX AFFYMETRIX INC | F Tax w/h | 2013-02-17 | 2013-02-19 | 1,097 | $3.85 | $4.2K | 91,099 | SEC↗ |
| AFFX AFFYMETRIX INC | A Award deriv | 2013-02-14 | 2013-02-19 | 50,000 | — | $0 | 50,000 | SEC↗ |
| AFFX AFFYMETRIX INC | A Award | 2013-02-14 | 2013-02-19 | 30,000 | — | $0 | 92,196 | SEC↗ |
| AFFX AFFYMETRIX INC | F Tax w/h | 2012-12-17 | 2012-12-18 | 1,835 | $3.32 | $6.1K | 60,696 | SEC↗ |
| AFFX AFFYMETRIX INC | F Tax w/h | 2012-08-19 | 2012-08-21 | 1,376 | $3.86 | $5.3K | 62,531 | SEC↗ |
| AFFX AFFYMETRIX INC | P Buy | 2012-08-03 | 2012-08-06 | 10,000 | $4.06 | $40.6K | 63,907 | SEC↗ |
| AFFX AFFYMETRIX INC | F Tax w/h | 2012-02-17 | 2012-02-22 | 1,048 | $4.61 | $4.8K | 53,907 | SEC↗ |